Celeris Therapeutics Is An Ai Driven Biotechnology Company That Focuses On Targeted Protein Degradation Therapies For Challenging Diseasetargetsfounded In 2020 And Headquartered In Menlo Parkcaliforniathecompany Also Has Offices In Grazaustriaand Londonukceleris Specializes In Addressing Neurodegenerativediseasessuch As Alzheimer S And Parkinson Sas Well As Various Cancers Through Its Proprietary Celeris Onea C Platform Theceleris Onea C Platform Employs Advanced Technologiesincluding Ai Driven Drug Designgenerativechemistryand Closed Loop Experimentationthis Allows For Therapid Identification And Optimization Of Small Moleculedegradersceleris Collaborates With Pharmaceutical And Biotech Companies To Co Develop Therapies And Also Runs In Houseprograms Aimed At Restoring Protein Homeostasis For Agerelated Diseases And Oncology Targetsthecompany Has Raised $18 09 Million In Funding And Is Led By Co Founders Jakob Hohenberger And Christopher Trummerwho Bring Expertisein Computational Biology And Drug Discovery
